On Friday, Shares of Microsoft Corporation (NASDAQ:MSFT), lost -0.38% to $46.70.
Microsoft Corporation declared that Windows 10 will become accessible Wednesday as a free upgrade1 or with new PCs and tablets. Windows 10 comprises innovations such as Cortana, an Xbox app and Microsoft Edge for a familiar, yet more personal and productive, experience. The most secure Windows ever, Windows 10 is delivered as a service and kept automatically up-to-date with innovations and security updates. Windows 10 offers one experience that will become accessible on the broadest range of devices, counting PCs, tablets, phones, Raspberry Pi, Xbox One, HoloLens and more — with more than 2,000 devices or configurations already in testing. The new Windows Store and Windows Software Development Kit also become available Wednesday, opening the door to new and innovative app experiences on Windows 10.
Windows 10 is more personal and productive, with voice, pen and gesture inputs for natural interaction with PCs. It’s designed to work with Office and Skype and allows you to switch between apps and stay organized with Snap and Task View. Windows 10 offers many innovative experiences and devices, counting the following:
- Cortana, the personal digital assistant, makes it easy to find the right information at the right time.
- New Microsoft Edge browser lets people quickly browse, read, and mark up and share the Web.
- The integrated Xbox app delivers the Xbox experience to Windows 10, bringing together friends, games and accomplishments across Xbox One and Windows 10 devices.
- Continuum optimizes apps and experiences beautifully across touch and desktop modes.
- Built-in apps counting Photos; Maps; Microsoft’s new music app, Groove; and Movies & TV offer entertainment and productivity options. With OneDrive, files can be easily shared and kept up-to-date across all devices.
- A Microsoft Phone Companion app enables iPhones, Android or Windows phones to work seamlessly with Windows 10 devices.
- The all new Office Mobile apps for Windows 10 tablets are accessible recently in the Windows Store.4 Built for work on-the-go, the Word, Excel and PowerPoint apps offer a consistent, touch-first experience for small tablets.
Microsoft Corporation develops, licenses, markets, and supports software, services, and devices worldwide. The company’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system.
Shares of Baxter International Inc. (NYSE:BAX), inclined 0.17% to $40.08, during its last trading session.
Baxter International on Wednesday stated second-quarter net income of $332 million, and earnings of $0.60 per diluted share. Second quarter 2015 results comprised of net after-tax special items totaling $218 million (or $0.40 per diluted share) primarily related to costs associated with the company’s spin-off of Baxalta, select business development initiatives and intangible asset amortization, partially offset by a benefit from a litigation settlement in which Baxter was the beneficiary. Second quarter 2014 results comprised of net after-tax charges totaling $172 million or ($0.31 per diluted share).
On an adjusted basis, not taking into account special items, Baxter’s second quarter net income totaled $550 million, or $1.00 per diluted share, surpassing the guidance the company formerly offered of $0.92 to $0.96 per diluted share.
Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
Finally, Mylan N.V. (NASDAQ:MYL), ended its last trade with -0.64% loss, and closed at $55.99.
Mylan declared that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its projected acquisition of Perrigo Company plc (NYSE: PRGO; TASE).
Mylan’s Executive Chairman Robert J. Coury commented, “Recently marks yet another important milestone in the process of concluding our acquisition of Perrigo and serves as further affirmation of the sound industrial logic of this compelling combination. We look forward to ongoing on this path and concluding the transaction in the coming months.”
As formerly declared, on April 24, 2015, Mylan issued a Rule 2.5 declaration (amended on April 29, 2015) under the Irish Takeover Rules setting forth its legally-binding commitment to commence an offer directly to the Perrigo shareholders for the entire issued and to be issued share capital of Perrigo. The projected transaction remains subject to certain conditions and other terms set forth in the formal Rule 2.5 declaration.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
